Massachusetts Water Resources Authority; Revenue - Utility, Water/Sewer Feb 00

  • ID: 1784551
  • February 2000
  • Region: Massachusetts
  • Standard & Poors
1 of 3

The rating on Massachusetts Water Resources Authority's bonds reflects: Substantial completion (98%) of the single-largest project ($3.43 billion) related to the Boston Harbor cleanupThe Deer Island Wastewater Treatment Plant. This limits the potential for increased project costs and allows for more realistic assumptions of future revenue requirements; Continued progress of financing the construction of mandated projects at lower-than-anticipated costs due to strong management and fortuitous inflation and interest rate environments; Still high but lower-than-projected retail rate needs; Annual state support, including a direct debt service subsidy for both sewer and water projects, and local tax raising flexibility; Strong management, which has generated strong reserves and solid liquidity; Very strong collection enforcement mechanisms, including state aid intercept and proactive, beneficial federal...

Companies mentioned in this report are:
- Massachusetts Wtr Resources Auth

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Massachusetts Wtr Resources Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.